29.04.2024 08:06:38 - dpa-AFX: *ASTRAZENECA SAYS TRUQAP + FASLODEX RECOMMENDED FOR APPROVAL IN EU FOR PATIENTS WITH ADVANCED ER-POSITIVE BREAST CANCER

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
ASTRAZENECA PLC DL-,25 886455 Xetra 141,850 17.05.24 14:38:52 ±0,000 ±0,00% 141,800 141,850 142,100 141,850

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH